StonvexLoading…
StonvexStonvexStonvexCore line items from CPAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $4.53B | $3.97B | $3.76B | $2.82B |
Operating Income | $1.99B | $1.79B | $1.66B | $1.23B |
Net Income | $1.07B | $1.00B | $981.89M | $726.03M |
EPS (Diluted) | $15.03 | $13.97 | $13.20 | $9.72 |
Total Assets | $26.41B | $17.96B | $15.48B | $15.67B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.41B | $1.55B | $1.39B | $2.80B |
Free Cash Flow OCF − CapEx | $1.30B | $1.77B | $1.95B | Not available |
Shares Outstanding | 68.36M | 70.17M | 71.72M | 74.73M |